124 related articles for article (PubMed ID: 85607)
1. The importance of the chemical state of 99mTc radiopharmaceuticals: an effective tumor imaging form of 99mTc bleomycin.
Yokoyama A; Terauchi Y; Horiuchi K; Okumura S; Saito Y; Tanaka H; Odori T; Morita R; Mori T; Torizuka K
Int J Appl Radiat Isot; 1978 Oct; 29(9-10):549-55. PubMed ID: 85607
[No Abstract] [Full Text] [Related]
2. Tin-absorbed resin for the preparation of 99mTc-radiopharmaceuticals: stable complex of 99mTc-bleomycin.
Horiuchi K; Yokoyama A; Fujibayashi Y; Tanaka H; Odori T; Saji J; Morita R; Torizuka K
Int J Appl Radiat Isot; 1981 Jan; 32(1):47-52. PubMed ID: 6162804
[No Abstract] [Full Text] [Related]
3. Pingyangmycin as a 99mTc carrier in tumor localization.
Huang T; Zhang Y; Wang J; Huang J; Liu D; Mong S
Nucl Med Biol; 1995 May; 22(4):537-42. PubMed ID: 7550032
[TBL] [Abstract][Full Text] [Related]
4. Chemical properties of technetium-99m-DL-homocysteine, a possible tumor-imaging agent.
Takeda A; Goto R; Okada S
Ann Nucl Med; 1988 Nov; 2(2):55-8. PubMed ID: 3275108
[TBL] [Abstract][Full Text] [Related]
5. Mononuclear and dinuclear complexes of 99mTc.
Yokoyama A; Horiuchi K
Int J Appl Radiat Isot; 1982 Oct; 33(10):929-36. PubMed ID: 6185442
[TBL] [Abstract][Full Text] [Related]
6. Bombesin derivative radiolabeled with technetium-99m as agent for tumor identification.
de Barros AL; Mota Ld; Ferreira Cde A; Oliveira MC; Góes AM; Cardoso VN
Bioorg Med Chem Lett; 2010 Nov; 20(21):6182-4. PubMed ID: 20850312
[TBL] [Abstract][Full Text] [Related]
7. What is the source of the skeletal affinity of 99mTc-V-DMSA?
Athanasoulis T; Koutsikos J; Zerva C
Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1673-4; author reply 1675-6. PubMed ID: 15452672
[No Abstract] [Full Text] [Related]
8. [Distribution study using 57Co-, 51Cr-, 111In- and 99mTc-bleomycin in mice with a solid Ehrlich carcinoma].
Zimmermann M; Hale T
Nuklearmedizin; 1976 Aug; 15(4):176-82. PubMed ID: 62345
[TBL] [Abstract][Full Text] [Related]
9. Use of Fe(II) or Sn(II) alone for technetium labeling of albumin.
Lin MS; Winchell HS; Shipley BA
J Nucl Med; 1971 May; 12(5):204-11. PubMed ID: 5580834
[No Abstract] [Full Text] [Related]
10. [Study on tumor affinity of 99mTc-labeled radiopharmaceuticals--99mTc-Sn-concanavaline A (author's transl)].
Itoh K; Kobayashi S; Hisada K; Tonami N; Ando A
Radioisotopes; 1977 Mar; 26(3):163-8. PubMed ID: 578933
[No Abstract] [Full Text] [Related]
11. [Clinical evaluation of tumor scintigraphy with 99mTc-bleomycin (Part I). Fundamental studies on labelling methods of 99mTc-bleomycin and its clinical application (author's transl)].
Odori T
Kaku Igaku; 1979 Aug; 16(5):721-33. PubMed ID: 94113
[No Abstract] [Full Text] [Related]
12. [A preliminary study of 57Ca-zhengguangmycin distribution in tumor-bearing mice and in clinical scanning (author's transl)].
Liu HT; Xue SB; Zhang HQ; Tang J; Zhang YM; Tian ZJ; Wang JX; Meng FY
Zhonghua Zhong Liu Za Zhi; 1979; 1(2):106-12. PubMed ID: 95441
[No Abstract] [Full Text] [Related]
13. Interaction of stannous ion with pyrrolidino-methyl tetracycline (PMT) in the preparation of PMT-99mTc radiopharmaceuticals.
Zmbova B; Zivanov-Stakić D; Tadzer I
Int J Appl Radiat Isot; 1981 Jul; 32(7):459-63. PubMed ID: 7263095
[No Abstract] [Full Text] [Related]
14. Technetium-99m complexes with steroid-2-aminooxyethyliminodiacetic acid conjugates.
Yoda R; Karube Y; Takata J; Nagata Y; Matsushima Y
Chem Pharm Bull (Tokyo); 1999 Mar; 47(3):413-6. PubMed ID: 10212390
[TBL] [Abstract][Full Text] [Related]
15. Liposomes radiolabeled with (159)Gd: in vitro antitumoral activity, biodistribution study and scintigraphic image in Ehrlich tumor bearing mice.
Soares DC; de Oliveira MC; de Barros AL; Cardoso VN; Ramaldes GA
Eur J Pharm Sci; 2011 Jul; 43(4):290-6. PubMed ID: 21605669
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and quality control of 99mTc-p-butyl IDA.
Zmbova B; Konstantinovska-Djokić D; Tadzer I
Int J Appl Radiat Isot; 1985 May; 36(5):389-94. PubMed ID: 4018899
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of 99mTc-labeled amino acids as radiopharmaceuticals. III. 99mTc complexes of ligands related to ethylenediamine-N,N-diacetic acid for tumor visualization.
Karube Y; Maeda T; Imoto T; Ohya M; Sugata S; Kono A; Okano H; Matsushima Y
Chem Pharm Bull (Tokyo); 1982 Jul; 30(7):2529-31. PubMed ID: 6814772
[No Abstract] [Full Text] [Related]
18. Role of serum albumin as a carrier of 99mTc-complex to tumor tissue.
Takeda A; Hibino T; Hoshino A; Okumura H; Okada S
Int J Rad Appl Instrum B; 1991; 18(5):499-502. PubMed ID: 1917519
[TBL] [Abstract][Full Text] [Related]
19. Comparison of intratumoral distribution of 99mTc-MIBI and deoxyglucose in mouse breast cancer models.
Ohira H; Kubota K; Ohuchi N; Harada Y; Fukuda H; Satomi S
J Nucl Med; 2000 Sep; 41(9):1561-8. PubMed ID: 10994739
[TBL] [Abstract][Full Text] [Related]
20. Tumor detection with some 99mTc-labeled S-containing amino acids.
Tamemasa O; Takeda A; Goto R
Gan; 1984 May; 75(5):395-402. PubMed ID: 6745561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
